Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Cherubini

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Transfusion|October 14, 2021
Trends and risk factors of SARS-CoV-2 infection in asymptomatic blood donorsLuca Valenti, Serena Pelusi, Alessandro Cherubini, et al.
Nature Communications|June 16, 2016
A Myc-driven self-reinforcing regulatory network maintains mouse embryonic stem cell identityLuca Fagnocchi, Alessandro Cherubini, Hiroshi Hatsuda, et al.
Nature Communications|March 11, 2018
MYC-driven epigenetic reprogramming favors the onset of tumorigenesis by inducing a stem cell-like stateVittoria Poli, Luca Fagnocchi, Alessandra Fasciani, et al.
Nature Communications|September 22, 2018
Author Correction: MYC-driven epigenetic reprogramming favors the onset of tumorigenesis by inducing a stem cell-like stateVittoria Poli, Luca Fagnocchi, Alessandra Fasciani, et al.
Pharmacological Research|November 21, 2025
Pyrazolone-based ERO1 inhibitors in ERO1-driven triple-negative breast cancer and SEPN1-related myopathy: Structure-activity relationship and therapeutic potentialMichele Retini, Alessandro Cherubini, Alice Marrazza, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 12, 2025
Targeting the Liver Serine Protease TMPRSS6 Ameliorates Steatosis and Attenuates Fibrosis in Experimental MASLDMariateresa Pettinato, Valeria Furiosi, Rossana Carleo, et al.
International Journal of Biological Sciences|December 12, 2024
Extracellular Vesicles from Human Induced Pluripotent Stem Cells Exhibit a Unique MicroRNA and CircRNA SignatureMario Barilani, Valeria Peli, Paolo Manzini, et al.
Nature Medicine|January 24, 2024
Author Correction: Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in womenAlessandro Cherubini, Mahnoosh Ostadreza, Oveis Jamialahmadi, et al.
Nature Medicine|September 25, 2023
Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in womenAlessandro Cherubini, Mahnoosh Ostadreza, Oveis Jamialahmadi, et al.
International Journal of Molecular Sciences|January 28, 2026
IFNAR2 p.F8S Variant Associates with Severe COVID-19 and Adaptive Immune Cell Activation ModulationFrancesco Malvestiti, Angela Lombardi, Francesco Gentile, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Transfusion|October 14, 2021
Trends and risk factors of SARS-CoV-2 infection in asymptomatic blood donorsLuca Valenti, Serena Pelusi, Alessandro Cherubini, et al.
Nature Communications|June 16, 2016
A Myc-driven self-reinforcing regulatory network maintains mouse embryonic stem cell identityLuca Fagnocchi, Alessandro Cherubini, Hiroshi Hatsuda, et al.
Nature Communications|March 11, 2018
MYC-driven epigenetic reprogramming favors the onset of tumorigenesis by inducing a stem cell-like stateVittoria Poli, Luca Fagnocchi, Alessandra Fasciani, et al.
Nature Communications|September 22, 2018
Author Correction: MYC-driven epigenetic reprogramming favors the onset of tumorigenesis by inducing a stem cell-like stateVittoria Poli, Luca Fagnocchi, Alessandra Fasciani, et al.
Pharmacological Research|November 21, 2025
Pyrazolone-based ERO1 inhibitors in ERO1-driven triple-negative breast cancer and SEPN1-related myopathy: Structure-activity relationship and therapeutic potentialMichele Retini, Alessandro Cherubini, Alice Marrazza, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 12, 2025
Targeting the Liver Serine Protease TMPRSS6 Ameliorates Steatosis and Attenuates Fibrosis in Experimental MASLDMariateresa Pettinato, Valeria Furiosi, Rossana Carleo, et al.
International Journal of Biological Sciences|December 12, 2024
Extracellular Vesicles from Human Induced Pluripotent Stem Cells Exhibit a Unique MicroRNA and CircRNA SignatureMario Barilani, Valeria Peli, Paolo Manzini, et al.
Nature Medicine|January 24, 2024
Author Correction: Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in womenAlessandro Cherubini, Mahnoosh Ostadreza, Oveis Jamialahmadi, et al.
Nature Medicine|September 25, 2023
Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in womenAlessandro Cherubini, Mahnoosh Ostadreza, Oveis Jamialahmadi, et al.
International Journal of Molecular Sciences|January 28, 2026
IFNAR2 p.F8S Variant Associates with Severe COVID-19 and Adaptive Immune Cell Activation ModulationFrancesco Malvestiti, Angela Lombardi, Francesco Gentile, et al.
Pageof 5